New data show the investigational Novartis meningitis B vaccine may be the first to also protect infants six months and older against multiple strains of potentially deadly meningococcal B bacteria. This second successful study of the vaccine in infants supports its potential to provide broad serogroup B strain coverage for both younger and older babies.
The details can be read here.
No comments:
Post a Comment